10X Genomics Inc
(TXG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 134,285 | 156,232 | 131,072 | 114,609 | 114,496 |
| Cost of Goods | 35,895 | 36,827 | 30,377 | 27,704 | 25,478 |
| Gross Profit | 98,390 | 119,405 | 100,695 | 86,905 | 89,018 |
| Operating Expenses | 151,273 | 143,328 | 141,068 | 150,726 | 131,231 |
| Operating Income | -51,988 | -23,096 | -39,996 | -63,117 | -41,735 |
| Interest Expense | 19 | 125 | 114 | 109 | 128 |
| Other Income | 2,353 | 6,810 | 75 | -605 | 169 |
| Pre-tax Income | -49,654 | -16,411 | -40,035 | -63,831 | -41,694 |
| Income Tax | 1,093 | 804 | 1,879 | 627 | 719 |
| Net Income Continuous | -50,747 | -17,215 | -41,914 | -64,458 | -42,413 |
| Net Income | $-50,747 | $-17,215 | $-41,914 | $-64,458 | $-42,413 |
| EPS Basic Total Ops | -0.44 | -0.14 | -0.37 | -0.57 | -0.38 |
| EPS Basic Continuous Ops | -0.44 | -0.15 | -0.37 | -0.57 | -0.38 |
| EPS Diluted Total Ops | -0.44 | -0.14 | -0.37 | -0.57 | -0.38 |
| EPS Diluted Continuous Ops | -0.44 | -0.15 | -0.37 | -0.57 | -0.38 |
| EBITDA(a) | $-43,372 | $-14,624 | $-31,881 | $-54,856 | $-33,577 |